7 news items
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
BAX
DVA
FMS
17 May 24
targets. However, recent performance improvements suggest a potential turnaround for the dialysis specialist.
Michael Sen
Truist Securities Maintains Hold on DaVita, Raises Price Target to $150
DVA
15 May 24
Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $135 to $150.
DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report
DVA
14 May 24
limiting the foregoing, statements including the words "expect," "intend," "will," "may," "continue," "target
6 Analysts Assess DaVita: What You Need To Know
DVA
6 May 24
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $137.83, with a high
Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $150
DVA
6 May 24
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $133 to $150.
w0v8xks92ixflkk txlpddg
ADAP
BDTX
DVA
23 Apr 24
apply global capabilities and perspectives to unlock high growth healthcare opportunities, targeting Pan-European and transatlantic internationalisation
77lz9o 477uu1vkgoybgckz35c21
DVA
22 Apr 24
operations. In 2021, DaVita set ambitious science-based targets as part of its 2025 Environmental, Social and Governance (ESG) goals—many of which were
- Prev
- 1
- Next